Insights into ultra-low affinity lipase-antibody noncovalent complex binding mechanisms
Detection of host cell protein (HCP) impurities is critical to ensuring that recombinant drug products, including monoclonal antibodies (mAbs), are safe. Mechanistic characterization as to how HCPs persist in drug products is important to refining downstream processing. It has been hypothesized that...
Saved in:
Main Authors: | Elizabeth Sara Hecht (Author), Shrenik Mehta (Author), Aaron T. Wecksler (Author), Ben Aguilar (Author), Nathaniel Swanson (Author), Wilson Phung (Author), Ananya Dubey Kelsoe (Author), W. Henry Benner (Author), Devin Tesar (Author), Robert F. Kelley (Author), Wendy Sandoval (Author), Alavattam Sreedhara (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Physicochemical and biological impact of metal-catalyzed oxidation of IgG1 monoclonal antibodies and antibody-drug conjugates via reactive oxygen species
by: Zephania Kwong Glover, et al.
Published: (2022) -
Natural-product-based, carrier-free, noncovalent nanoparticles for tumor chemo-photodynamic combination therapy
by: Zhonglei Wang, et al.
Published: (2024) -
Discovery of potent and noncovalent KRASG12D inhibitors: Structure-based virtual screening and biological evaluation
by: Yuting Wang, et al.
Published: (2022) -
Antigen physiochemical properties allosterically effect the IgG Fc-region and Fc neonatal receptor affinity
by: Yue Sun, et al.
Published: (2020) -
Discovery of Potential Noncovalent Inhibitors of Dehydroquinate Dehydratase from Methicillin-Resistant <i>Staphylococcus aureus</i> through Computational-Driven Drug Design
by: César Millán-Pacheco, et al.
Published: (2023)